GSK Prescribes A US$3.5bn Bond In Three Parts By: TalkMarkets March 19, 2019 at 16:06 PM EDT British pharma GlaxoSmithKline joined the recent groundswell of high-grade corporate bond issuers Monday to sell new debt. Read More >> Related Stocks: Apple Bristol-Myers Squibb Celgene Corp Gilead Sciences Gsk Plc ADR Microsoft Novartis Ag ADR Pfizer Walgreens Boots Alliance
